Here, I will give you my 5 minutes of DD on AGN's patent structure and business model..
Algernon's focus is to take genericized drugs that have never been approved in the U. S. or Europe, and find if they have efficacy in new diseases.
These drugs have never been used in the United States, so why find them elsewhere and bring them back?
Well, if you take a genericized drug that's used in the U. S. and you find a new use for it, you will come up against the potential for physicians to do what's known as "off label prescription writing". So, Algernon specifically looks for drugs that are either developed by either Japan or Russia, test them on animals for new diseases, finds a "signal", and then files new intellectual property. All of these drugs are off patent, but Algernon files new methods of use patents and files structure patents around that core compound. The other way of protection Algernon uses is through formulation, which is an additional layer.
I'm not sure what there isn't to understand here. That "post" you brought here is from a poster that is incapable of doing his/her our due diligence. I left StockHouse for this very reason (hardly any dd, mostly nonsense and stupid questions). This poster has stated many times that AGN lowered the pp price from .58 cents down to .35 cents (completely false) and nobody would call him on it. His DD is comprised of asking questions on StockHouse, alot of questions. That's just sad Imo.
AMG called this loser out many times for his ignorance, and the best bearinthewoods could come back with was poking fun at AMGs StockHouse name.
Ask yourself this, why is this poster so interested in Algernon if his/her opinion of the company that of a drugless scam?
He/she is either "Short" and trying to persuade nieve newcomers or HAS NO LIFE.
Algernon does have some real issues hiding in the shadows, and they're already paying the price for that, but their business model and patent process isn't one of them.
B. O. B.
